MARKET

BCTX

BCTX

Briacell Therapeutics Corp
NASDAQ
4.160
-0.030
-0.72%
After Hours: 4.206 +0.046 +1.09% 16:20 05/11 EDT
OPEN
4.220
PREV CLOSE
4.190
HIGH
4.310
LOW
4.130
VOLUME
93.55K
TURNOVER
--
52 WEEK HIGH
37.20
52 WEEK LOW
3.600
MARKET CAP
30.16M
P/E (TTM)
-0.1278
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BCTX last week (0504-0508)?
Weekly Report · 14h ago
BriaCell adds NYU Langone Perlmutter as site for Phase 3 breast cancer trial
PUBT · 4d ago
BRIACELL ADDS NYU LANGONE HEALTH’S PERLMUTTER CANCER CENTER AS CLINICAL SITE IN PIVOTAL PHASE 3 BREAST CANCER STUDY
Reuters · 4d ago
BriaCell receives FDA clearance to initiate Bria-BRES+ trial
TipRanks · 4d ago
BriaCell Therapeutics Receives FDA Clearance To Initiate Clinical Evaluation Of Bria-BRES+, Its Next Generation Cell-Based Immunotherapy For Metastatic Breast Cancer
Benzinga · 5d ago
BriaCell wins FDA clearance to start Bria-BRES+ metastatic breast cancer study
PUBT · 5d ago
BRIACELL THERAPEUTICS CORP - TO INITIATE PHASE 1/2A STUDY OF BRIA-BRES+ IN COMING MONTHS
Reuters · 5d ago
Weekly Report: what happened at BCTX last week (0427-0501)?
Weekly Report · 05/04 09:07
More
About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTX stock methods without spending real money on the virtual paper trading platform.